| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1540-8159.1988.TB06349.X |
| P698 | PubMed publication ID | 2463587 |
| P2093 | author name string | A C Thomas | |
| S A Moser | |||
| P A Wilson | |||
| M L Smutka | |||
| P433 | issue | 11 Pt 2 | |
| P304 | page(s) | 2053-2058 | |
| P577 | publication date | 1988-11-01 | |
| P1433 | published in | Pacing and Clinical Electrophysiology | Q2740882 |
| P1476 | title | Implantable defibrillation: eight years clinical experience | |
| P478 | volume | 11 |
| Q43880489 | A Technique for the Prevention of Automatic Implantable Cardioverter Defibrillator Generator Migration |
| Q77299220 | Antiarrhythmic drugs and devices for the management of ventricular tachyarrhythmia in ischemic heart disease |
| Q68190780 | Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system |
| Q52213143 | Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillation. |
| Q54325876 | Cardiomyopathy and the Use of Implanted Cardio-Defibrillators in Children |
| Q56271168 | Causes of death in the antiarrhythmics versus implantable defibrillators (AVID) trial |
| Q35651017 | Clinical experience with the transvenous Medtronic Pacer Cardioverter Defibrillator (PCD) System |
| Q33145156 | Combining antiarrhythmic drugs and implantable devices therapy: benefits and outcome |
| Q43770711 | Comparison of efficacy of automatic implantable cardioverter defibrillator in patients older and younger than 65 years of age. |
| Q33777287 | Concomitant device and drug therapy: current trends, potential benefits, and adverse interactions |
| Q40404084 | Current approaches in patients with ventricular tachyarrhythmias |
| Q41564303 | Current concepts in electrical defibrillation |
| Q73832139 | Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: randomized comparison of patient response criteria |
| Q72095994 | Effective Defibrillation in Pigs Using Interleaved and Common Phase Sequential Biphasic Shocks |
| Q67685481 | Fate of Explanted ICD Patients |
| Q71566654 | Impact of the implantable defibrillator on mortality: the axiom of overall implantable cardioverter-defibrillator survival |
| Q36675792 | Implantable Cardioverter Defibrillators in Cardiovascular Practice: Report of the Policy Conference of the North American Society of Pacing and Electrophysiology |
| Q44692922 | Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified? |
| Q38756165 | Implantable cardioverters and defibrillators |
| Q40991178 | Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias |
| Q77299224 | Interactions between implantable cardioverter-defibrillators and class III agents |
| Q41089643 | Interactions between pharmacologic and nonpharmacologic antiarrhythmic therapy |
| Q49276497 | Intraperitoneal migration of an AICD generator placed in a posterior rectus pocket |
| Q44517867 | Long-Term Community Hospital Experience with the Internal Defibrillator |
| Q41830791 | Long-Term Efficacy of an Antitachycardia Pacemaker and Implantable Defibrillator Combination |
| Q40595299 | Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants |
| Q68060388 | Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group |
| Q34085399 | Matching cardiac rhythm management technology to patient needs: pacing/ablation/implantable cardioverter defibrillators |
| Q30441812 | Nonpharmacological Therapy of Ventricular Arrhythmias |
| Q67685476 | Occurrence of ICD Shocks and Patient Survival |
| Q40485755 | Patient Survival Comparison in Three Generations of Automatic Implantable Cardioverter Defibrillators: Review of 12 Years, 25,000 Patients |
| Q33173726 | Potential Hazards of Fixed Gain Sensing and Arrhythmia Reconfirmation for Implantable Cardioverter Defibrillators |
| Q52007770 | Securing life through technology acceptance: the first six months after transvenous internal cardioverter defibrillator implantation. |
| Q67685468 | Sudden Death Mortality in Implantable Cardioverter Defibrillator Patients |
| Q73236634 | Sudden Electrical Death |
| Q77947832 | Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation |
| Q72072520 | The Effect of Bidisomide (SC‐40230), a New Class Ia/Ib Antiarrhythmic Agent, on Defihrillation Energy Requirements in Dogs with Healed Myocardial Infarctions |
| Q40485884 | The Effect of the Implantable Cardioverter Defibrillator on Sudden Death and on Total Survival |
| Q33145454 | The implantable cardioverter-defibrillator. |
| Q26829026 | The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis |
Search more.